XML 51 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue (Tables)
 12 Months Ended
Apr. 26, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The table below illustrates net sales by segment and division for fiscal years 2019, 2018, and 2017:
 
 Net Sales by Fiscal Year
(in millions)
2019
 
2018
 
2017
Cardiac Rhythm & Heart Failure
$
5,849

 
$
5,947

 
$
5,649

Coronary & Structural Heart
3,730

 
3,562

 
3,113

Aortic, Peripheral & Venous
1,926

 
1,845

 
1,736

Cardiac and Vascular Group
11,505

 
11,354

 
10,498

Surgical Innovations
5,753

 
5,537

 
5,145

Respiratory, Gastrointestinal, & Renal
2,725

 
3,179

 
4,774

Minimally Invasive Therapies Group
8,478

 
8,716

 
9,919

Spine
2,654

 
2,668

 
2,641

Brain Therapies
2,604

 
2,354

 
2,098

Specialty Therapies
1,641

 
1,556

 
1,491

Pain Therapies
1,284

 
1,165

 
1,136

Restorative Therapies Group
8,183

 
7,743

 
7,366

Diabetes Group
2,391

 
2,140

 
1,927

Total
$
30,557

 
$
29,953

 
$
29,710

The tables below include net sales by market geography and segment for fiscal years 2019, 2018, and 2017:
 
U.S.(1) 
 
Non-U.S. Developed Markets(2)
 
Emerging Markets(3)
(in millions)
Fiscal Year 2019
 
Fiscal Year 2018
 
Fiscal Year 2019
 
Fiscal Year 2018
 
Fiscal Year 2019
 
Fiscal Year 2018
Cardiac and Vascular Group
$
5,750

 
$
5,681

 
$
3,767

 
$
3,790

 
$
1,988

 
$
1,883

Minimally Invasive Therapies Group
3,630

 
3,804

 
3,250

 
3,378

 
1,598

 
1,534

Restorative Therapies Group
5,478

 
5,164

 
1,759

 
1,720

 
946

 
859

Diabetes Group
1,336

 
1,226

 
855

 
739

 
200

 
175

Total
$
16,194

 
$
15,875

 
$
9,631

 
$
9,627

 
$
4,732

 
$
4,451

 
U.S.(1) 
 
Non-U.S. Developed Markets(2)
 
Emerging Markets(3)
(in millions)
Fiscal Year 2018
 
Fiscal Year 2017
 
Fiscal Year 2018
 
Fiscal Year 2017
 
Fiscal Year 2018
 
Fiscal Year 2017
Cardiac and Vascular Group
$
5,681

 
$
5,454

 
$
3,790

 
$
3,393

 
$
1,883

 
$
1,651

Minimally Invasive Therapies Group
3,804

 
5,049

 
3,378

 
3,479

 
1,534

 
1,391

Restorative Therapies Group
5,164

 
5,012

 
1,720

 
1,588

 
859

 
766

Diabetes Group
1,226

 
1,148

 
739

 
625

 
175

 
154

Total
$
15,875

 
$
16,663

 
$
9,627

 
$
9,085

 
$
4,451

 
$
3,962

(1)
U.S. includes the United States and U.S. territories.
(2)
Non-U.S. developed markets include Japan, Australia, New Zealand, Korea, Canada, and the countries within Western Europe.
(3)
Emerging markets include the countries of the Middle East, Africa, Latin America, Eastern Europe, and the countries of Asia that are not included in the non-U.S. developed markets, as defined above.